Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100
- 31 March 2009
- journal article
- Published by Elsevier BV in Experimental Hematology
- Vol. 37 (3), 402-415.e1
- https://doi.org/10.1016/j.exphem.2008.10.017
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilizationBlood, 2009
- Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal modelHaematologica, 2008
- AMD3100 synergizes with G-CSF to mobilize repopulating stem cells in Fanconi anemia knockout miceExperimental Hematology, 2008
- CXCR4 is required for the quiescence of primitive hematopoietic cellsThe Journal of Experimental Medicine, 2008
- Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemiaBlood, 2007
- Hematopoietic Progenitor Cells (HPC) from Mobilized Peripheral Blood Display Enhanced Migration and Marrow Homing Compared to Steady-State Bone Marrow HPCExperimental Hematology, 2007
- Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonistBlood, 2003
- Collection of hematopoietic stem cells from patients with autoimmune diseasesBone Marrow Transplantation, 2001
- Donating stimulated peripheral blood stem cells vs bone marrow: do donors experience the procedures differently?Bone Marrow Transplantation, 2001
- Impaired Production and Increased Apoptosis of Neutrophils in Granulocyte Colony-Stimulating Factor Receptor–Deficient MiceImmunity, 1996